[
  {
    "ts": null,
    "headline": "Inari Medical, now part of Stryker, launches the all-new InThrill® Thrombectomy System, designed to address arteriovenous access and small vessel thrombus cases",
    "summary": "Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectomy System, the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system that can deliver fast, full luminal clot removal.",
    "url": "https://finnhub.io/api/news?id=14da57b974f539ca65424ed7c2bbc4260a168df2dbcb5ecb2700810f998b1e7c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753794420,
      "headline": "Inari Medical, now part of Stryker, launches the all-new InThrill® Thrombectomy System, designed to address arteriovenous access and small vessel thrombus cases",
      "id": 136119360,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectomy System, the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system that can deliver fast, full luminal clot removal.",
      "url": "https://finnhub.io/api/news?id=14da57b974f539ca65424ed7c2bbc4260a168df2dbcb5ecb2700810f998b1e7c"
    }
  },
  {
    "ts": null,
    "headline": "Will SYK's Q2 Earnings Reflect Strong Growth Despite Tariff Overhang?",
    "summary": "Stryker's second-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs and tariffs are likely to have continued to hurt margins.",
    "url": "https://finnhub.io/api/news?id=1ff9ac176ab37f73e1a84dbca5e27626c9aeb54c7007e611a6352223baecbea1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753793640,
      "headline": "Will SYK's Q2 Earnings Reflect Strong Growth Despite Tariff Overhang?",
      "id": 136119361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Stryker's second-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs and tariffs are likely to have continued to hurt margins.",
      "url": "https://finnhub.io/api/news?id=1ff9ac176ab37f73e1a84dbca5e27626c9aeb54c7007e611a6352223baecbea1"
    }
  },
  {
    "ts": null,
    "headline": "Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott",
    "summary": "The Europe defibrillator market, valued at USD 3.87 billion in 2024, is projected to reach USD 7.23 billion by 2033, with a CAGR of 7.2%. Growth drivers include rising cardiovascular diseases, technological advancements, and government initiatives to expand public defibrillator access. Key segments include implantable and external defibrillators with significant usage in hospitals, public, and home settings. The market faces challenges such as high device costs and regulatory complexities. Leadi",
    "url": "https://finnhub.io/api/news?id=907abd71e0acf14c85f08841aca27b3d4c98ed558bc2e3023b6b30a4cb1eb943",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753778280,
      "headline": "Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott",
      "id": 136117045,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "The Europe defibrillator market, valued at USD 3.87 billion in 2024, is projected to reach USD 7.23 billion by 2033, with a CAGR of 7.2%. Growth drivers include rising cardiovascular diseases, technological advancements, and government initiatives to expand public defibrillator access. Key segments include implantable and external defibrillators with significant usage in hospitals, public, and home settings. The market faces challenges such as high device costs and regulatory complexities. Leadi",
      "url": "https://finnhub.io/api/news?id=907abd71e0acf14c85f08841aca27b3d4c98ed558bc2e3023b6b30a4cb1eb943"
    }
  },
  {
    "ts": null,
    "headline": "Franklin Rising Dividends Fund Q2 2025 Commentary",
    "summary": "US stocks advanced during the second quarter of 2025, despite a sharp pullback in early April.",
    "url": "https://finnhub.io/api/news?id=d14cdbc32a80a01923c282ada34fd60b4afe278e86ff1800925d818cac8d9bf3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753775700,
      "headline": "Franklin Rising Dividends Fund Q2 2025 Commentary",
      "id": 136116764,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2187192503/image_2187192503.jpg?io=getty-c-w1536",
      "related": "SYK",
      "source": "SeekingAlpha",
      "summary": "US stocks advanced during the second quarter of 2025, despite a sharp pullback in early April.",
      "url": "https://finnhub.io/api/news?id=d14cdbc32a80a01923c282ada34fd60b4afe278e86ff1800925d818cac8d9bf3"
    }
  }
]